These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7182602)

  • 1. Changes in the FDP (fibrin and fibrinogen degradation products) value under mental and physical stress. I. Changes in FDP and other indices of physio-biochemical effects of stress loaded on volleyball players during training.
    Omoto M; Furuichi S; Igarashi M; Yoshida M; Suzuki Y; Shiba T
    Sangyo Igaku; 1982 Nov; 24(6):608-15. PubMed ID: 7182602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the FDP (fibrin and fibrinogen degradation products) value under mental and physical stress. II. Simultaneous observations of FDP and other indices of fatigue in persons under experimentally loaded stress.
    Omoto M; Furuichi S; Imai T; Nomura R; Hokama Y; Igarashi M
    Sangyo Igaku; 1982 Nov; 24(6):616-27. PubMed ID: 7182603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can physical exercise induce an effective fibrinolysis?
    Dufaux B; Order U; Hollmann W
    Thromb Res; 1984 Oct; 36(1):37-43. PubMed ID: 6209819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin/fibrinogen degradation products (FDP) in urine and serum after prolonged heavy exercise.
    Arnesen H; Akesson I; Strömme SB; Refsum HE
    Scand J Haematol; 1976 Apr; 16(4):279-84. PubMed ID: 935811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen/fibrin degradation products and D-dimer in clinical practice: interpretation of discrepant results.
    Sato N; Takahashi H; Shibata A
    Am J Hematol; 1995 Mar; 48(3):168-74. PubMed ID: 7864025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological behavior of higher molecular weight products of fibrinolysis.
    Chang ML; Bang NU
    J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of extravasation in pelvic fracture using coagulation biomarkers.
    Aoki M; Hagiwara S; Tokue H; Shibuya K; Kaneko M; Murata M; Nakajima J; Sawada Y; Isshiki Y; Ichikawa Y; Oshima K
    Injury; 2016 Aug; 47(8):1702-6. PubMed ID: 27267962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
    Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayasaki J; Hayakawa M
    Clin Lab; 2018 Apr; 64(4):433-442. PubMed ID: 29739066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin/fibrinogen degradation products in late pregnancy promote macrosomia prediction in normal uncomplicated pregnancy.
    Yuan X; Gao Y; Zhang M; Long W; Liu J; Wang H; Yu B; Xu J
    Placenta; 2020 Jul; 96():27-33. PubMed ID: 32560855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation and fibrinolysis disorder in muscular dystrophy.
    Saito T; Takenaka M; Miyai I; Yamamoto Y; Matsumura T; Nozaki S; Kang J
    Muscle Nerve; 2001 Mar; 24(3):399-402. PubMed ID: 11353426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of dialysate fibrin degradation products and lactic dehydrogenase isoenzyme patterns in assessing the clinical course of peritonitis.
    Suzuki K; Ishizaki M; Hotta O; Horigome I; Sudo K; Kurosawa K; Taguma Y
    Perit Dial Int; 1994; 14(3):231-5. PubMed ID: 7948233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
    Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinogen and fibrinogen/fibrin degradation products in the urine of rabbits infected with Trypanosoma (trypanozoon) brucei.
    Boreham PF; Facer CA
    Z Parasitenkd; 1977 Jul; 52(3):257-65. PubMed ID: 906631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.